Downregulation of LMIR-3 in DCs enhances T cell proliferation initiated by DCs, as well as antigen-specific T cell responses, both in vitro and in vivo, leading to effective protection against tumor challenge in mice (39). Here, CD300LF is linked to neoplasm.